The perfect stock to own right now?

Stantec reports Q3 2026 results after Thursday’s close, and the number that matters most will not be the headline earnings figure. It will be organic growth.

Analysts are forecasting $1.24 in earnings per share on $1.30 billion in revenue for the quarter. Both are achievable. Last quarter, Stantec earned $1.16 per share, edging past the $1.15 consensus, while net margin sat at 5.91% and return on equity at 19.70%. The company has a habit of modest beats. The real debate is whether the back half of the year delivered the organic acceleration management explicitly promised.

That promise was specific. Organic growth was flat in Q2 due to the conclusion of several large projects and slower-than-anticipated ramp-ups for new infrastructure and environmental contracts, but management said acceleration to high single digits was expected in the second half of 2026 as delayed projects in the West and South regions entered full execution. Thursday is the first chance to see whether that call holds.

There is also a mechanical tailwind baked into Q3. The Page acquisition transitions from acquisition growth to organic growth starting this quarter, providing a mathematical boost to organic metrics. So any reported organic acceleration needs to be read with that in mind. A jump that is entirely Page flipping the reporting clock is not the same as underlying demand responding.

The underlying demand, however, is genuinely strong. Stantec’s backlog stood at $9.24 billion as of June 30, up $1.37 billion, or 17.5%, from a year earlier. Water led organically in Q1 with 14.3% growth, and Energy and Resources added 8.6%. The water business then delivered over 20% organic growth in Q2 through long-term framework agreements and public sector investments in the U.K., Australia, and New Zealand. These are not one-off contract wins; they are multi-year programs tied to regulatory water modernization cycles that do not turn off because a quarter slows.

Backlog size alone, however, does not settle the execution question. Boeing’s experience shows how a record order book can coexist with persistent delivery shortfalls and constrained cash flow.

The leadership change also lands squarely on this report. Susan Reisbord becomes CEO on October 1, 2026, making Thursday her first earnings release in the chair. Reisbord is a 30-year industry veteran who joined Stantec via the 2021 Cardno acquisition and previously served as North America COO. The reaffirmed 2026 net revenue growth guidance of 8.5% to 11.5% is the bar she will be measured against, and how she handles continued integration of the Page acquisition will shape investor confidence in execution risk over the next several years.

Scotiabank raised its FY2026 EPS estimate to $4.51 in late October, above the company’s own guidance ceiling of $4.49, and carries an Outperform rating. The broader analyst consensus sits at a Moderate Buy with a $175 target price. At current levels, the stock is priced for steady execution, not for a surprise. The risk is not that Stantec misses by a wide margin. The risk is that organic growth comes in and looks more like Page math than genuine demand, leaving the second-half acceleration story unproven heading into 2027.

The broader earnings backdrop adds another layer to that risk. A record-setting Q2 reporting season has reset the bar so high that steady execution no longer moves stocks the way it once did.

Watch the backlog figure first, water organic growth second, and what Reisbord says about the U.S. pipeline third. Those three numbers will tell you more than the EPS line ever will.